Last week, we discussed Merck & Co.’s pill intended to treat coronaviruses. Well, according to a recent article from The Hill, Pfizer has one now too. The treatment is a protease inhibitory similar to those used to treat HIV and hepatitis C. It binds to the viral enzyme and prevents it from replicating in the cell. Pfizer has begun preclinical studies, which have demonstrated “potent in vitro anti-viral activity against SARS-CoV-2, as well as activity against other coronaviruses.”
Pfizer Has A COVID-19 Treatment Pill
Pfizer is testing a new oral antiviral that treats SARS-CoV-2 and other coronaviruses.
Mar 30, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
